Levofloxacino Aristo

Levofloxacin, the active ingredient in Levofloxacino Aristo, is a fluoroquinolone presented as an oral dosage form for oral use. It is employed to treat a range of bacterial infections, including urinary, respiratory, skin, prostatitis, and gonorrhea, in adult patients.

GNH USA supplies Levofloxacino Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and ensuring consistent batch release and regulatory compliance for global distribution.

Levofloxacin is a fluoroquinolone antibacterial that interferes with bacterial DNA replication and is indicated for several infection types.

- Urinary tract infections: eradicates susceptible uropathogens and relieves urinary symptoms. - Respiratory tract infections: treats community‑acquired pneumonia, acute exacerbations of chronic bronchitis, and other bacterial respiratory diseases. - Skin and soft tissue infections: resolves infections caused by susceptible Gram‑positive and Gram‑negative organisms. - Prostatitis: achieves bacterial clearance in chronic bacterial prostatitis. - Gonorrhea: provides microbiological cure of uncomplicated gonococcal infection.

Levofloxacin may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles tendon. - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe allergic reaction: rash, angioedema, or anaphylaxis requiring immediate medical attention.

Levofloxacino Aristo requires careful consideration of patient‑specific factors and proper handling. - Renal function assessment: adjust therapy in patients with impaired renal clearance. - Hypersensitivity screening: avoid use in individuals with known allergy to fluoroquinolones. - Elderly caution: monitor for tendon pain and central nervous system effects. - Concomitant QT‑prolonging drugs: evaluate cardiac risk before co‑administration. - Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Levofloxacin can interact with several medication classes, influencing safety and efficacy.

Major Interactions (Avoid): - Other fluoroquinolones: additive toxicity risk. - QT‑prolonging agents (e.g., quinidine, amiodarone): increased risk of arrhythmia. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened tendon‑rupture risk.

Moderate Interactions (Monitor Closely): - Antacids or supplements containing magnesium/aluminum: may reduce levofloxacin absorption. - Warfarin: potential alteration of INR, requiring coagulation monitoring. - Corticosteroids: synergistic effect on tendon toxicity. - Oral contraceptives: possible reduction in contraceptive efficacy.